With many US states legalizing psilocybin for medical treatment, questions arise about whether this psychedelic drug, the most thoroughly researched of its kind, could transform how depression and other mental health conditions are treated. The article examines the potential for psilocybin to revolutionize psychiatric care as regulatory approval expands.
Roland Griffiths, an American psychopharmacologist who revived psychedelic research, was described by a curator as serious, gentle, and straight-laced yet deeply calm and spiritual. Upon learning his stage 4 colon cancer was likely terminal, he advised his mentee to view his impending death as an opportunity to feel.